Skip to main content

Some call it conformability. 
We call it one less thing for you to worry about.


Device conformability can reduce complications in patients with aortic disease requiring reintervention.1-3 That is why we design our aortic devices to adapt to the patient's unique anatomy.

At Gore, our portfolio of conformable stent grafts and innovative delivery systems allows us to support physicians in improving clinical outcomes in EVAR and TEVAR procedures, providing what matters to the patients: Long-lasting treatment. 
 

    Aortic endoprosthesis designed to respect the anatomy 

    Gore strives to redefine the standard of conformability. A device achieves conformability by combining radial force, device flexibility and spring-back force.

    The GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System exhibited exceptional conformability based on results of spring-back analysis.

     

    Elements of conformability

    arrow-narrow-down-red

    Low tendency
    to spring back

    product-1-red

    Exceptional flexibility
    while maintaining an open lumen

    human-body-red

    Designed to adapt
    to the anatomy

    Endovascular aortic repair devices to provide controlled conformability

    Controlled conformability for each patient – building on the proven performance of the GORE® EXCLUDER® Device family, i.e. the conformable stent graft and innovative delivery system, offers new levels of control.

     

      Gore has combined a stent design, device conformability and an enhanced delivery system to give physicians even more control when we need it most.

      Dr. Robert Rhee / Chief of Vascular and Endovascular Surgery, Maimonides Medical Center in Brooklyn, New York, National Principal Investigator

      Most studied EVAR and TEVAR devices


      We are a world leader in membrane technology and biomaterials and we are dedicated to creating durable quality that is built to last, to help give patients back their quality time. By undertaking comprehensive quality assessments, we develop trusted aortic solutions used in 675,000+ devices worldwide.* Our EVAR and TEVAR devices are the most studied worldwide†,‡ — a proven and durable option to treat patients.
       

      Clinical studies-red

      Most studied
      EVAR and TEVAR devices

      VSX icon-red

      Exceptional flexibility
      while maintaining an open lumen

      GORE® TAG® Conformable Thoracic Stent Graft 
      Anatomy through five-year follow-up3 
       

      Image
      TAG_Adapting_to_aortic_anatomy_pre-treatment


      Pre-treatment

      Image
      TAG_Adapting_to_aortic_anatomy_1_year


      One year follow-up

      Image
      TAG_Adapting_to_aortic_anatomy_2_years


      Two year follow-up


      Image
      TAG_Adapting_to_aortic_anatomy_3_years


      Three year follow-up

      Image
      TAG_Adapting_to_aortic_anatomy_4_years


      Four year follow-up

      Image
      TAG_Adapting_to_aortic_anatomy_5_years


      Five year follow-up

      GORE® EXCLUDER® 
      Conformable AAA Endoprosthesis§
       

      Image
      Pre-treatment


      Pre-treatment

      Image
      Twelve-month follow-up


      12-month follow-up

      GORE® EXCLUDER® 
      Iliac Branch Endoprosthesis§
       

      Image
      Pre-treatment


      Pre-treatment

      Image
      48-month follow-up


      48-month follow-up


      A focus on the future, driven by a powerful past

      At Gore, we have a strong heritage in material science leadership. Since the late 60s, Gore has been diving deep into material innovations and more for than 25 years, our devices are setting the standards for aortic care. But we have not stopped there. We continue to drive aortic innovations that will help physicians deliver the best possible care to their patients. 
      We’re your aortic ally.

      Endografts designed to treat both straightforward and challenging anatomies

      Our family of EVAR and TEVAR devices is designed for everyday practice and the treatment of highly challenging aortic pathologies. They all have one goal in common: Advancing aortic treatment capabilities. 

      GORE® ACTIVE CONTROL System in EVAR and TEVAR

      The GORE® ACTIVE CONTROL System is designed to increase the physician's confidence in deployment. It allows accurate device positioning and location refinement before full deployment and continuous blood flow throughout the entire procedure.

       


        * Data on file, W. L. Gore & Associates, Inc; Flagstaff, AZ.

        † Based on company-sponsored trials and registries shown on clinicaltrials.gov for currently available stent grafts.

        ‡ 10 FDA approved clinical studies.

        § Images from actual case study.

        1. Incidence and outcomes after infolding or collapse of thoracic stent grafts Kasirajan, Karthikeshwar et al. Journal of Vascular Surgery, Volume 55, Issue 3, 652 - 658.
           
        2. New C-TAG device overcome of compression events K. Kasirajan Journal of Cardiovascular Surgery, Volume 53, No. 2, 169-172.XX
           
        3. Donas KP, Inchingolo M, Cao P, et al; pELVIS Registry Collaborators. Secondary procedures following iliac branch device treatment of aneurysms involving the iliac bifurcation: The pELVIS Registry. Journal of Endovascular Therapy 2017;24(3):405-410. 
        IFU Consult instructions

        Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. RXOnly

        GORE® TAG® Conformable Thoracic Stent Graft
        INDICATIONS FOR USE IN EUROPE: The GORE® TAG® Conformable Thoracic Stent Graft is indicated for endovascular repair of all lesions of the descending thoracic aorta, including isolated lesions, such as aneurysm and traumatic transection, and Type B dissections.

        CONTRAINDICATIONS: The GORE® TAG® Conformable Thoracic Stent Graft is contraindicated in:

        • Patients with known sensitivities or allergies to the device materials  
        • Patients with a systemic infection who may be at increased risk of endovascular graft infection

        GORE® EXCLUDER® Conformable AAA Endoprosthesis
        INDICATIONS FOR USE IN EUROPE: Trunk-Ipsilateral Leg Endoprosthesis and Contralateral Leg Endoprosthesis Components
        The GORE® EXCLUDER® Conformable AAA Endoprosthesis is intended to exclude the aneurysm from the blood circulation in patients diagnosed with infrarenal abdominal aortic aneurysm (AAA) disease and who have appropriate anatomy as described below:

        • Adequate iliac / femoral access  
        • Infrarenal aortic neck treatment diameter range of 16–32 mm  
        • A minimum aortic neck length of 10 mm when proximal aortic neck angulation is ≤ 60°  
        • A minimum aortic neck length of 15 mm when proximal aortic neck angulation is ≤ 90°  
        • Iliac artery treatment diameter range of 8–25 mm and iliac distal vessel seal zone length of at least 10 mm

        Aortic Extender Endoprosthesis and Iliac Extender Endoprosthesis Components 
        The Aortic and Iliac Extender Endoprostheses are intended to be used after deployment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis. These extensions are intended to be used when additional length and / or sealing for aneurysmal exclusion is desired.

        CONTRAINDICATIONS: The GORE® EXCLUDER® Conformable AAA Endoprosthesis is contraindicated in:

        • Patients with known sensitivities or allergies to the device materials.  
        • Patients with a systemic infection who may be at increased risk of endovascular graft infection.

         

        GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE) 
        INDICATIONS FOR USE IN EUROPE: Iliac Branch and Internal Iliac Components
        The GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE) is intended to isolate the common iliac artery from systemic blood flow and preserve blood flow in the external iliac and internal iliac arteries in patients with a common iliac or aortoiliac aneurysm, who have appropriate anatomy, including:  

        1. Adequate iliac / femoral access  
        2. Minimum common iliac diameter of 17 mm at the proximal implantation zone of the IBE  
        3. External iliac artery treatment diameter range of 6.5–25 mm and seal zone length of at least 10 mm
        4. Internal iliac artery treatment diameter range of 6.5–13.5 mm and seal zone length of at least 10 mm

        Trunk-Ipsilateral Leg and Contralateral Leg Endoprosthesis Components 
        The Trunk-Ipsilateral Leg and Contralateral Leg Endoprostheses are intended to provide proximal seal and fixation to the GORE® EXCLUDER® Iliac Branch Endoprosthesis following deployment of the GORE® EXCLUDER® Iliac Branch Endoprosthesis. For more information on the Trunk-Ipsilateral Leg and Contralateral Leg Endoprosthesis Component indications for use and deployment, see the GORE® EXCLUDER® AAA Endoprosthesis and GORE® EXCLUDER® Conformable Endoprosthesis Instructions for Use.  

        Aortic Extender Endoprosthesis and Iliac Extender Endoprosthesis Components 
        The Aortic and Iliac Extender Endoprostheses can be used after deployment of the GORE® EXCLUDER® Iliac Branch and AAA Endoprostheses. These extensions are used when additional length and / or sealing for aneurysmal exclusion is desired. For more information on Aortic Extender and Iliac Extender indications for use and deployment, see the GORE® EXCLUDER® AAA Endoprosthesis and GORE® EXCLUDER® Conformable Endoprosthesis Instructions for Use.

        CONTRAINDICATIONS: The GORE® EXCLUDER® Iliac Branch Endoprosthesis is contraindicated in:

        • Patients with known sensitivities or allergies to the device materials.
        • Patients with a systemic infection who may be at increased risk of endovascular graft infection.
        Product may not be available in all countries. Please check with your Gore representative for availability.